13F-HR filed by Venrock Adviser, LLC
Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 26 holding rows worth $731,539,000.
- Accession
- 0001104659-22-022702
- Filer
- CIK 1615982
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 26 entries on the cover page, a total value of $731,539,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $731,539,000 with VALUE read as thousands by filing date, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Instil Bio, Inc. | 45783C101 | Common Stock | 6,865,076 | $117,461,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 4,563,962 | $66,360,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,994,997 | $61,925,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,270,072 | $51,145,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 2,021,985 | $47,173,000 | thousands by filing date | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,529,402 | $36,935,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,852,919 | $36,632,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 2,880,096 | $34,216,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 865,116 | $33,428,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 3,494,851 | $33,411,000 | thousands by filing date | |
| LIANBIO ADR | 53000N108 | COM | 5,378,341 | $33,131,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 16,047,286 | $31,292,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 1,283,821 | $20,939,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 1,612,617 | $20,045,000 | thousands by filing date | |
| NUVALENT INC COM | 670703107 | Stock | 803,951 | $15,307,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 773,014 | $13,698,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,000,000 | $13,030,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,127,272 | $12,693,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120202 | COM NEW | 1,565,000 | $11,691,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,088,817 | $9,342,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 1,428,571 | $7,886,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 816,651 | $7,644,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 533,370 | $6,523,000 | thousands by filing date | |
| AKOYA BIOSCIENCES INC COM | 00974H104 | Stock | 400,000 | $6,124,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 538,999 | $2,905,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 250,000 | $603,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-22-022702 | this filing | 2022-02-14 | acceptance time not in the bulk data set |